NovaSom provides technology-driven, payer-aligned home testing and management solutions for obstructive sleep apnea, including an FDA-cleared Home Sleep Test (HST) system and cloud-based MediTrack Patient Management Portals. The company’s home service delivery model connects physicians, therapy providers and payers to align patient preference, cost and quality objectives, and its HST service is described as clinically equivalent to lab-based studies for OSA detection. NovaSom is a Medicare-approved Independent Diagnostic Testing Facility and is accredited by The Joint Commission as both an Ambulatory Care Sleep Diagnostic Center and a Telehealth provider. The company integrates its home sleep testing system into a collaborative, cloud-based patient management platform for physicians and payers. NovaSom will use the $35 million financing to fund growth, expand its leadership in payer and provider markets, and develop additional innovations within its proprietary NovaSom diagnostic device and MediTrack portals. Safeguard Scientifics' participation and the board appointment of James A. Datin are presented as strategic endorsements to accelerate adoption among payers and providers.

Total raised

$35M

Funding rounds

1

Latest round

Series D

Latest activity

Jun 2011